Oral preexposure prophylaxis to prevent HIV infection: Clinical and public health implications

被引:1
|
作者
Baker, Jonathan [1 ]
O'Hara, Kevin Michael [2 ]
机构
[1] Univ Pittsburgh Pa Med Ctr, Div Infect Dis, Pittsburgh, PA 15261 USA
[2] Yale Univ, PA Program, New Haven, CT USA
关键词
HIV; preexposure prophylaxis (PrEP); tenofovir; emtricitabine (FTC); antiretroviral; harm reduction; TENOFOVIR DISOPROXIL FUMARATE; IMMUNODEFICIENCY-VIRUS; UNITED-STATES; ANTIRETROVIRAL PROPHYLAXIS; COST-EFFECTIVENESS; MEN; RISK; SEX; TRANSMISSION; EMTRICITABINE;
D O I
10.1097/01.JAA.0000456567.37724.e0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article reviews the use of combination emtricitabine (FTC)/tenofovir as preexposure prophylaxis (PrEP) for HIV-negative patients at high risk of acquiring HIV, including heterosexual men and women, men who have sex with men, and IV drug users. When used with classic prevention strategies such as condoms, PrEP has been found effective in reducing the risk of HIV transmission.
引用
收藏
页码:10 / 17
页数:8
相关论文
共 50 条
  • [21] Effectiveness and safety of oral HIV preexposure prophylaxis for all populations
    Fonner, Virginia A.
    Dalglish, Sarah L.
    Kennedy, Caitlin E.
    Baggaley, Rachel
    O'Reilly, Kevin R.
    Koechlin, Florence M.
    Rodolph, Michelle
    Hodges-Mameletzis, Ioannis
    Grant, Robert M.
    AIDS, 2016, 30 (12) : 1973 - 1983
  • [22] HIV Preexposure Prophylaxis and Condomless Sex: Disentangling Personal Values From Public Health Priorities
    Calabrese, Sarah K.
    Underhill, Kristen
    Mayer, Kenneth H.
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2017, 107 (10) : 1572 - 1576
  • [23] Systemic Preexposure Prophylaxis for HIV: Translating Clinical Data to Clinical Practice
    Li, Julius
    Dufrene, Staci L.
    Okulicz, Jason F.
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (04) : 507 - 518
  • [24] The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion
    Donnell, Deborah
    Ramos, Eric
    Celum, Connie
    Baeten, Jared
    Dragavon, Joan
    Tappero, Jordan
    Lingappa, Jairam R.
    Ronald, Allan
    Fife, Kenneth
    Coombs, Robert W.
    AIDS, 2017, 31 (14) : 2007 - 2016
  • [25] Ethical considerations regarding oral preexposure prophylaxis in HIV prevention trials
    Sugarman, Jeremy
    CURRENT OPINION IN HIV AND AIDS, 2016, 11 (01) : 109 - 115
  • [26] Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada
    Knox, David C.
    Pilarski, Robert
    Dhunna, Harvinder S.
    Kaushal, Amit
    Adachi, Jonathan D.
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2022, 2022
  • [27] Serosorting Sexual Partners by Gay and Bisexual Men to Prevent HIV Infection: Implications for Public Health Clinicians
    Blackwell, Christopher W.
    PUBLIC HEALTH NURSING, 2015, 32 (05) : 555 - 564
  • [28] Recent HIV Infection: Diagnosis and Public Health Implications
    Nikolopoulos, Georgios K.
    Tsantes, Andreas G.
    DIAGNOSTICS, 2022, 12 (11)
  • [29] What do Dutch MSM think of preexposure prophylaxis to prevent HIV-infection? A cross-sectional study
    Bil, Janneke P.
    Davidovich, Udi
    van der Veldt, Wendy M.
    Prins, Maria
    de Vries, Henry J. C.
    Sonder, Gerard J. B.
    Stolte, Ineke G.
    AIDS, 2015, 29 (08) : 955 - 964
  • [30] Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services
    Liu, Albert Y.
    Cohen, Stephanie E.
    Vittinghoff, Eric
    Anderson, Peter L.
    Doblecki-Lewis, Susanne
    Bacon, Oliver
    Chege, Wairimu
    Postle, Brian S.
    Matheson, Tim
    Amico, K. Rivet
    Liegler, Teri
    Rawlings, M. Keith
    Trainor, Nikole
    Blue, Robert Wilder
    Estrada, Yannine
    Coleman, Megan E.
    Cardenas, Gabriel
    Feaster, Daniel J.
    Grant, Robert
    Philip, Susan S.
    Elion, Richard
    Buchbinder, Susan
    Kolber, Michael A.
    JAMA INTERNAL MEDICINE, 2016, 176 (01) : 75 - 84